Sequentify, a Weizmann Institute of Science spinoff, enables fast and focused DNA sequencing. It combines tools from the synthetic biology and AI software fields to enable rapid targeted DNA sequencing. Sequentify exits stealth mode with $7M in raised funds led by Israel's most active venture firm, OurCrowd. The funds will be used to accelerate R&D, delivery, and go-to-market plans for the company.

Founded in 2021 as a Weizmann Institute of Science spinoff, Sequentify provides a technology that is based on tools from the synthetic biology and AI software worlds for targeted DNA sequencing applications such as cancer diagnostics, carrier screening, COVID-19 surveillance and other applications. Sequentify is based in Rehovot, Israel. For more information, visit https://www.sequentify.com/.

https://www.sequentify.com/

Privacy And Security

Artificial Intelligence

Science And Engineering

Health Care

Information Technology

Software

Hardware

Sequentify

Democratizing Genomics, Sequentify Raises $7M To Enable Dna Sequencing At Scale

Democratizing Genomics, Sequentify Raises $7M To Enable Dna Sequencing At Scale

Description

Company Information

Democratizing Genomics, Sequentify Raises $7M To Enable Dna Sequencing At Scale

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Company Information